PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer (Q39178894)
Jump to navigation
Jump to search
scientific article published on 21 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer |
scientific article published on 21 May 2013 |
Statements
1 reference
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer (English)
1 reference
1 reference
Paola Muzi
1 reference
Margherita Piccolella
1 reference
Marcella Motta
1 reference
Ernesto Di Cesare
1 reference
Vincenzo Tombolini
1 reference
Claudio Festuccia
1 reference
21 May 2013
1 reference
1 reference
20
1 reference
3
1 reference
321-337
1 reference
Identifiers
1 reference
1 reference